Compare · HSIC vs XRAY
HSIC vs XRAY
Side-by-side comparison of Henry Schein Inc. (HSIC) and DENTSPLY SIRONA Inc. (XRAY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. HSIC focuses on Medical Specialities, while XRAY focuses on Medical/Dental Instruments.
- HSIC is the larger of the two at $10.15B, about 3.6x XRAY ($2.86B).
- Over the past year, HSIC is up 36.2% and XRAY is down 1.2% - HSIC leads by 37.4 points.
- HSIC has been more active in the news (6 items in the past 4 weeks vs 3 for XRAY).
- Both have 25 recent analyst ratings on file.
- Company
- Henry Schein Inc.
- DENTSPLY SIRONA Inc.
- Price
- $88.40-0.82%
- $13.87-2.87%
- Market cap
- $10.15B
- $2.86B
- 1M return
- +1.81%
- +13.83%
- 1Y return
- +36.17%
- -1.21%
- Industry
- Medical Specialities
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1995
- 1987
- News (4w)
- 6
- 3
- Recent ratings
- 25
- 25
Henry Schein Inc.
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials; and laboratory-based CAD/CAM milling systems, amalgamators, mixing machines, and porcelain furnaces. In addition, it provides dental technology products, including dental implants and related scanning equipment, and treatment software; orthodontic clear aligners and appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, dental handpieces, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers; dental hygienists, assistants, laboratories, and schools; and urology products directly to patients, as well as through distributors to urologists, continence care nurses, general practitioners, and direct-to-patients. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.
Latest HSIC
- SEC Form 10-Q filed by Henry Schein Inc.
- Henry Schein Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Henry Schein Reports Strong Second Quarter 2026 Financial Results and Raises FY2026 Guidance
- Henry Schein Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Henry Schein Announces Leadership Transitions
- Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET
- BMO Capital Markets initiated coverage on Henry Schein with a new price target
- GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide
- SEC Form 11-K filed by Henry Schein Inc.
- Director Daniel William K was granted 2,215 shares, increasing direct ownership by 41% to 7,641 units (SEC Form 4)
Latest XRAY
- Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship
- SEC Form 3 filed by new insider Fortson John C.
- Dentsply Sirona to Host Second Quarter Conference Call on August 6th
- BMO Capital Markets initiated coverage on Dentsply Sirona with a new price target
- PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry
- SEC Form 4 filed by Director Mazelsky Jonathan Jay
- SEC Form S-8 filed by DENTSPLY SIRONA Inc.
- Amendment: Director Mazelsky Jonathan Jay bought $101,400 worth of shares (10,000 units at $10.14), increasing direct ownership by 19% to 61,669 units (SEC Form 4)
- New insider Barton-Brobst Lindi Rene claimed ownership of 45,440 shares (SEC Form 3)
- Director Hosein Clyde bought $64,902 worth of shares (6,500 units at $9.98), increasing direct ownership by 10% to 70,575 units (SEC Form 4)